📅 Nov 5 | 10 AM PT / 1 PM ET
👉 Register:
buff.ly/vJWYcdw
📅 Nov 5 | 10 AM PT / 1 PM ET
👉 Register:
buff.ly/vJWYcdw
📅 Nov 5 | 10 AM PT / 1 PM ET
👉 Register:
buff.ly/vJWYcdw
📅 Nov 5 | 10 AM PT / 1 PM ET
👉 Register:
buff.ly/vJWYcdw
Yiguang Zhu successfully defended his dissertation: “Advancing Regulatory Acceptance of CIVMs: A Two-Phase Validation and Qualification Framework.
Yiguang celebrated with family, friends, colleagues, and his adviser, Paul Locke.
Yiguang Zhu successfully defended his dissertation: “Advancing Regulatory Acceptance of CIVMs: A Two-Phase Validation and Qualification Framework.
Yiguang celebrated with family, friends, colleagues, and his adviser, Paul Locke.
#PRIMTECH3R is a project that aims to develop reliable mouse & human #CIVMs for preclinical studies, in order to replace, reduce and refine the use of animal models
🔗 Read more here by our project partner #EuroBioImaging: buff.ly/V875GTU
🧵 13/14
#PRIMTECH3R is a project that aims to develop reliable mouse & human #CIVMs for preclinical studies, in order to replace, reduce and refine the use of animal models
🔗 Read more here by our project partner #EuroBioImaging: buff.ly/V875GTU
🧵 13/14
🗓️ Jan 30 @ 1 pm CET
More 🔽
www.eurobioimaging.eu/news/introdu...
🗓️ Jan 30 @ 1 pm CET
More 🔽
www.eurobioimaging.eu/news/introdu...
More 🔽
www.eurobioimaging.eu/news/develop...
More 🔽
www.eurobioimaging.eu/news/develop...
go.nature.com/47hfRBY